The document provides data on FDA orphan drug approvals from 1983 to 2014, the decreasing cost of genome sequencing, and annual total returns for healthcare and S&P 500 from 2011 to 2015. It discusses the impact of political uncertainty on healthcare investments and suggests favoring tech, financials, and consumer discretionary sectors. The document includes data from Deutsche Bank Wealth Management and FactSet.
documents/vol00010-efta01459677-pdf.pdf
{"title":"Equity Sectors: An 'Appreciation' for Innovation and Demographics","document_type":"tabular","key_organizations":["Deutsche Bank Wealth Management","FactSet"]}